Skip to main content

Ambry Genetics Purchases Illumina HiSeq, BeadXpress


This article was orignally published Aug. 25.

Ambry Genetics has acquired an Illumina HiSeq 2000 sequencer for its service business, along with an Illumina BeadXpress genotyping system.

The HiSeq will allow the Aliso Viejo, Calif.-based firm "to run large projects for its customers while saving costs and providing the fastest turnaround times for sequencing," according to a company statement. Ambry has provided sequencing services on the Illumina Genome Analyzer since 2007.

Ambry, which has a CAP-accredited and CLIA-certified clinical laboratory, offers both genomic services and genetic diagnostic and carrier testing.

An Illumina-certified service provider, it currently provides a variety of sequencing services on the GAIIx, including whole-genome sequencing, exome sequencing, and RNA sequencing. For targeted sequencing, the company uses the Agilent SureSelect, RainDance, and Roche NimbleGen enrichment methods.

This spring, Ambry said it was working on a sequencing-based genetic carrier screening test to assay known mutations involved in more than 90 genetic diseases (IS 5/18/2010).

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.